CTOs on the Move

International Association for Medical Assisance

www.iamat.org

 
International Association for Medical Assisance to Travelers is a Guelph, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.iamat.org
  • 40 Regal Rd
    Guelph, ON CAN N1K 1B5
  • Phone: 716.754.4883

Executives

Name Title Contact Details

Similar Companies

Sono Bello

Sono Bello is a national leader in total body transformation providing micro-laser™ liposuction and customized, in-office facial rejuvenation procedures – which deliver incredible, natural-looking results.

Merion Gardens Assisted Living

Merion Gardens Assisted Living is a Penns Grove, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Equipping Youth

Equipping Youth is a Cedar Rapids, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Apria

Apria Healthcare is one of the nation`s leading providers of home respiratory services and certain medical equipment, including oxygen therapy, inhalation therapies, sleep apnea treatment, and negative pressure wound therapy. Apria was the first such company to obtain voluntary accreditation from the Joint Commission and has been continuously accredited for more than 25 consecutive years. Apria operates more than 290 service locations throughout the United States and serves more than 2 million patients each year. In many cases, it`s a new beginning for its patients with the chance to return home from the hospital to resume their lives. What makes Apria industry leading is its focus on the patient as well as its employees. The people who work at Apria have passion and a commitment to excellence and we foster that compassion. Apria employees continually enhance their skills, receive training, and exhibit the kind of professionalism that makes Apria a highly effective and knowledgeable resource for our patients and healthcare customers.

Menlo Therapeutics

We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.